Price Chart

Profile

Axonics Inc is a United States-based medical technology company. It focuses on developing and commercializing novel products for adults with bladder and bowel dysfunction, that include implantable SNM systems to treat urinary urge incontinence and urinary urgency frequency (UUF); a urethral bulking agent (Bulkamid) to treat female stress urinary incontinence. SNM therapy is primarily used to treat patients with overactive bladder, fecal incontinence, and urinary retention.
URL https://www.axonics.com
Investor Relations URL https://ir.axonics.com/
HQ State/Province California
Sector Healthcare
Industry Medical Devices
Equity Style Small Cap/Growth
Next Earnings Release May. 01, 2024 (est.)
Last Earnings Release Oct. 30, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Axonics Inc is a United States-based medical technology company. It focuses on developing and commercializing novel products for adults with bladder and bowel dysfunction, that include implantable SNM systems to treat urinary urge incontinence and urinary urgency frequency (UUF); a urethral bulking agent (Bulkamid) to treat female stress urinary incontinence. SNM therapy is primarily used to treat patients with overactive bladder, fecal incontinence, and urinary retention.
URL https://www.axonics.com
Investor Relations URL https://ir.axonics.com/
HQ State/Province California
Sector Healthcare
Industry Medical Devices
Equity Style Small Cap/Growth
Next Earnings Release May. 01, 2024 (est.)
Last Earnings Release Oct. 30, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A